Vaccine Hesitancy: A Contemporary Issue for New COVID‑19 Vaccination

Pathum Sookaromdee, Viroj Wiwanitkti

Abstract


There are some recent reports of vaccine hesitancy globally toward the new coronavirus disease 2019 (COVID‑19) vaccines. Vaccine hesitancy is an important issue to be discussed in preventive medicine. There are many factors that can lead to vaccine hesitancy.

Keywords


COVID‑19; vaccine Hesitancy; vaccine

Full Text:

PDF

References


MacDonald NE. Vaccine hesitancy: Definition, scope and

determinants. Vaccine 2015;33:4161‑4.

Chou WY, Budenz A. Considering Emotion in COVID‑19

vaccine communication: Addressing vaccine hesitancy and

fostering vaccine confidence. Health Commun 2020;35:1718‑22.

Ababneh NA, Bakri FG, Mahafzah A. High rates of COVID‑19

vaccine hesitancy and its association with conspiracy beliefs:

A study in Jordan and Kuwait among other Arab Countries.

Vaccines 2021;9:42.

Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B.

Trust in a COVID‑19 vaccine in the US: A social‑ecological

perspective. Soc Sci Med 2021;270:113684.

Sookaromdee P, Wiwanitkit V. New COVID‑19 vaccines, its

cost and shelf life: A cost effectiveness analysis. Arch Med Res

;52:453.

Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT,

Zhang B, et al. Factors associated with US Adults’ likelihood

of accepting COVID‑19 vaccination. JAMA Netw Open

;3:e2025594.

Burki T. The online anti‑vaccine movement in the age of

COVID‑19. Lancet Digit Health 2020;2:e504‑5.